Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Cell Metabolism 2018

About Conference


International Conference on 2nd Annual summit on Cell Metabolism is bustling to be held at Philadelphia, USA during September 19-20, 2018 hosted by Conferences Series. Through the theme "Emerging approach and innovations in the field of Cell Metabolism", conference will explore the advances in Cell Signaling Technologies, Cell Metabolism, Medical Approaches, Oncology, Translational Oncology, Computational Technologies, etc. This conference brings a novel and International mixture of giant and medium cancer therapy and cell signaling analysis, leading universities and cancer analysis establishments creating the conference an excellent platform to share expertise, foster collaborations across trade and world, and assess rising technologies across the world.

Conference Series Organizes 1000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members. To know more about the conference series visit: http://conferenceseries.com/.

Cell Metabolism is an extensive field in modern medical practice and diagnosis. The global digital cancer market, is expected to garner $111.9 billion by 2020, registering a CAGR of 7.1% during the forecast period 2014 to 2020.Chemotherapy would continue to be the highest revenue generating segment through 2020. The global Cancer therapy market is estimated to grow at 17.6% CAGR to reach $52.2billion by 2021. Breast cancer therapy is the largest market expected to reach $30.8 billion by 2016 at an estimated CAGR of 15%.

Who Should Attend?

Practicing cancer biologists in training and other healthcare professionals interested in the latest advances and techniques in the field. Another segment of target audience is Pharmaceutical researchers, Clinical organizations, Educational institutes. Computational Bioinformatacian, Translational Oncologists, Surgical Cancer Researchers etc.,

The First International Conference and Exhibition on Cell Signaling and Cancer Therapy will exhibit the products and services from commercial and non-commercial organizations like Clinical Lab Equipment manufacturers, Cell Diagnostics laboratories, Clinical Trial Sites, Business delegates and Equipment Manufacturers.

Why to attend Cell Metabolism 2018?

  • Best platform to develop new partnership & collaborations.
  • Sharpen your skills and become a expert to their particular field.
  • Best location to speed up your route into every territory in the World.
  • Gain new ideas, tools & tactics.
  • Conferences are great way to refuel yourself and chances to shine.
  • 90% our conference attendees are the Key contact in their labs purchasing decisions.
  • Our exhibitor booths were visited 4-5 times by 80% of the attendees during the conference.
  • Network development with both Academia and Business.

Sessions/Tracks

Track: Cell Metabolism

Cells are regularly carrying out thousands of chemical reactions needed to keep the cell, and your body as a whole, alive and healthy. These chemical reactions are often linked together in chains, or pathways. All of the chemical reactions that take place inside of a cell are collectively called the cell’s metabolism.

To obtain a sense of the complexity of metabolism, let's take a look at the metabolic diagram below. To me, this mess of lines looks like a map of a very large subway system, or possibly a fancy circuit board. In fact, it's a diagram of the core metabolic pathways in a eukaryotic cell, essentially the cells that make up the human body. Each line is a reaction, and each circle is a reactant or product.

Related conferences

26th World Cancer Convention November 27-28, 2017 Dubai, UAE; Experts Meet On Cancer Therapy 2018 July 11-12, 2018 Sydney, Australia; Global Summit on Oncology & Cancer March 12-14, 2018 Singapore; 3rd International Conference on Nuclear Medicine & Radiation Therapy March 26-27, 2018 Edinburgh, Scotland; 22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan; 9th World Biomarkers Congress December 07-08, 2017 Madrid, Spain; 27th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany; Global Meeting on Oncology and Radiology April 16-17, 2018 Dubai, UAE; 4th Annual Conference on Gynecologic Oncology July 18-19, 2018 Atlanta, USA;

Track: Metabolic pathways

In biochemistry, a metabolic pathway is a combined series of chemical reactions occurring within a cell. The reactants, products, and intermediates of an enzymatic reaction are known as metabolites, which are modified by a sequence of chemical reactions catalyzed by enzymes. In a metabolic pathway, the product of one enzyme accomplishes as the substrate for the next. These enzymes often require dietary minerals, vitamins, and other cofactors to function. There are two types of metabolic pathways that are characterized by their ability to either synthesize molecules with the utilization of energy (anabolic pathway) or break down of complex molecules by releasing energy in the process (catabolic pathway). The two pathways complement each other in that the energy released from one is used up by the other.

Related conferences

4th Annual Conference on Gynecologic Oncology July 18-19, 2018 Atlanta, USA; World Haematology and Medical Oncology Conference May 28-30, 2018 Osaka, Japan; International Conference on Robotic Oncology October 26-27, 2018 Osaka, Japan; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2018 Rome, Italy; 3rd Oncologist & Diagnostics Conference 2018 September 20-21, 2018 Germany, Berlin; 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA; 4th Annual Conference on Preventive oncology July 18-19, 2018 Atlanta, USA; 28th Euro Congress on Cancer Science & Therapy August 09-10, 2018 Madrid, Spain;

Track: Metabolic disease Therapies

Convenient metabolic regulation is essential for good health and well-being. The body is challenged on a daily basis with environmental and behavioral stresses that require adjustments in the type and quantity of fuels that oxidized for energy. When this ability to reciprocate to metabolic stress becomes impaired, it can lead to a number of diseases and disorders that are generally referred to as metabolic disease. Metabolic diseases affect a large proportion of the US population and have a substantial impact on the mortality rate and quality of life for afflicted individuals. Hence, many researchers are pursuing a better understanding of the underlying factors that lead to the development of metabolic diseases, the consequences of metabolic dysregulation, and the therapeutic strategies that can effectively counter the causes and consequences of this dysregulation.

Related conferences

26th World Cancer Convention November 27-28, 2017 Dubai, UAE; Experts Meet On Cancer Therapy 2018 July 11-12, 2018 Sydney, Australia; Global Summit on Oncology & Cancer March 12-14, 2018 Singapore; 3rd International Conference on Nuclear Medicine & Radiation Therapy March 26-27, 2018 Edinburgh, Scotland; 22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan; 9th World Biomarkers Congress December 07-08, 2017 Madrid, Spain; 27th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany; Global Meeting on Oncology and Radiology April 16-17, 2018 Dubai, UAE; 4th Annual Conference on Gynecologic Oncology July 18-19, 2018 Atlanta, USA; 

Track: Neuro Immune Axis

To scrutinize the interface between the nervous and immune systems during development, homeostasis, and disease. The meeting will examine the mediators, mechanisms, and implications of neuro-immune crosstalk in the central and peripheral nervous systems. It will also cover originating areas such as the neuronal regulation of peripheral immune function and the influence of the microbiota on the brain. We will bring together researchers from across the fields of neuroscience and immunology to facilitate discussion of exciting new concepts and developments in both fields.

Related conferences

27th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany; Global Meeting on Oncology and Radiology April 16-17, 2018 Dubai, UAE; 4th Annual Conference on Gynecologic Oncology July 18-19, 2018 Atlanta, USA; World Haematology and Medical Oncology Conference May 28-30, 2018 Osaka, Japan; International Conference on Robotic Oncology October 26-27, 2018 Osaka, Japan; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2018 Rome, Italy; 3rd Oncologist & Diagnostics Conference 2018 September 20-21, 2018 Germany, Berlin; 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA; 4th Annual Conference on Preventive oncology July 18-19, 2018 Atlanta, USA; 28th Euro Congress on Cancer Science & Therapy August 09-10, 2018 Madrid, Spain;

Track: Emerging re-emerging viruses

Human pathogenic viruses are regularly emerging and re-emerging, as highlighted by the recent Ebola outbreak in West Africa and the ongoing Zika virus outbreak in the Americas. By focusing on a range of human pathogenic viruses, this meeting will center on understanding and establishing common principles to help combat current and future viral threats. Starting with basic host-virus biology, the meeting will intent to ask how basic research can inform our understanding of emerging and re-emerging viruses to help with surveillance as well as vaccine and drug development. The meeting will bring infectious-disease researchers of many stripes together with scientists interested in the host response to these viruses from immunological, cell-biological, and pharmacological perspectives.

Related conferences

26th World Cancer Convention November 27-28, 2017 Dubai, UAE; Experts Meet On Cancer Therapy 2018 July 11-12, 2018 Sydney, Australia; Global Summit on Oncology & Cancer March 12-14, 2018 Singapore; 3rd International Conference on Nuclear Medicine & Radiation Therapy March 26-27, 2018 Edinburgh, Scotland; 22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan; 9th World Biomarkers Congress December 07-08, 2017 Madrid, Spain; 27th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany; Global Meeting on Oncology and Radiology April 16-17, 2018 Dubai, UAE; 4th Annual Conference on Gynecologic Oncology July 18-19, 2018 Atlanta, USA;

Track: Human Immunity

Immunologists study the immune system to asset human health, as a multitude of disorders, ranging from cancer to infectious, autoimmune and metabolic diseases, have an underlying basis rooted in immunity. While we have experienced important advances in immune-based therapies for many types of diseases in recent years, the complexity of human biology and the diversity that makes each of us unique mannerism outstanding challenges to translate basic knowledge into effective treatments. In addition, the technological advances and the advent of big data approaches also offer incredible opportunities to discover new biological principles that govern the functioning of the human immune system during homeostasis and disease. 

Related conferences

Global Summit on Oncology & Cancer March 12-14, 2018 Singapore; 3rd International Conference on Nuclear Medicine & Radiation Therapy March 26-27, 2018 Edinburgh, Scotland; 22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan; 9th World Biomarkers Congress December 07-08, 2017 Madrid, Spain; 27th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany; Global Meeting on Oncology and Radiology April 16-17, 2018 Dubai, UAE; 4th Annual Conference on Gynecologic Oncology July 18-19, 2018 Atlanta, USA; World Haematology and Medical Oncology Conference May 28-30, 2018 Osaka, Japan; 

Track: Next gen Immunology

The immune system has the unique capacity to merge with almost every tissue in the body to promote protection against threats and to preserve organismal homeostasis. Understanding how immune cells adapt their function to the needs of each distinct tissue environment is challenging. It requires thinking about immunity in the ambience of a whole organism, where immune function is integrated to other physiological systems such as the nervous system, metabolic tissues and barrier sites – as well as to our meta-organismal partner: the microbiome.

Related conferences

27th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany; Global Meeting on Oncology and Radiology April 16-17, 2018 Dubai, UAE; 4th Annual Conference on Gynecologic Oncology July 18-19, 2018 Atlanta, USA; World Haematology and Medical Oncology Conference May 28-30, 2018 Osaka, Japan; International Conference on Robotic Oncology October 26-27, 2018 Osaka, Japan; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2018 Rome, Italy; 3rd Oncologist & Diagnostics Conference 2018 September 20-21, 2018 Germany, Berlin; 

Track: Translational immunometabolism

The field of immunometabolism has flourished over the last decade, revealing not only the major roles played by immune cells in metabolic homeostasis but also the impact of metabolic pathways on immune cell function. As new discoveries continue to reveal the intricate links between immunology and metabolism, a key question arises: will our accumulated knowledge on immunometabolic deregulations translate into novel therapies for human diseases? In this topic will focus how local and systemic metabolism are integrated at the cellular level to regulate immune cell function and will focus on how novel insights into immunometabolism can be utilised to advance and/or bolster therapeutic interventions in metabolic diseases, inflammation, autoimmunity, and cancer.

Related conferences

9th World Biomarkers Congress December 07-08, 2017 Madrid, Spain; 27th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany; Global Meeting on Oncology and Radiology April 16-17, 2018 Dubai, UAE; 4th Annual Conference on Gynecologic Oncology July 18-19, 2018 Atlanta, USA; World Haematology and Medical Oncology Conference May 28-30, 2018 Osaka, Japan; International Conference on Robotic Oncology October 26-27, 2018 Osaka, Japan; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2018 Rome, Italy; 3rd Oncologist & Diagnostics Conference 2018 September 20-21, 2018 Germany, Berlin; 

Track: Translational Regulation in Development and Disease

Transcriptional Regulation in Development and Disease will import together researchers studying developmental biology and its disruption in disease with those examining the specific molecular and cellular mechanisms of transcriptional regulation.

Related conferences

4th Annual Conference on Gynecologic Oncology July 18-19, 2018 Atlanta, USA; World Haematology and Medical Oncology Conference May 28-30, 2018 Osaka, Japan; International Conference on Robotic Oncology October 26-27, 2018 Osaka, Japan; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2018 Rome, Italy; 3rd Oncologist & Diagnostics Conference 2018 September 20-21, 2018 Germany, Berlin; 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA; 4th Annual Conference on Preventive oncology July 18-19, 2018 Atlanta, USA; 28th Euro Congress on Cancer Science & Therapy August 09-10, 2018 Madrid, Spain;

Track: Aging and Metabolism

As organisms age, switch over time occurs as a layered process, from molecular modifications to shifts in tissue homeostasis, ultimately leading to systemic transformations. Alterations in metabolism are found throughout the hierarchy of change and can be integral to the relationship between aging and disease as well as to the impact of aging on physiological processes such as inflammation and immunity.  Recent studies have contributed new insight into how the perturbation of metabolic factors can accelerate or impair aging processes.  Furthermore, there is a growing appreciation for the role of aging in the immune response and the need to take this phenomenon into account when considering therapeutic approaches, from vaccines to precision medicine.  It is an exciting time to consider the multifactorial nature of aging, the new biological discoveries being made, and how to translate these insights to human health as longevity reaches unprecedented levels worldwide.

Related conferences

Global Summit on Oncology & Cancer March 12-14, 2018 Singapore; 3rd International Conference on Nuclear Medicine & Radiation Therapy March 26-27, 2018 Edinburgh, Scotland; 22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan; 9th World Biomarkers Congress December 07-08, 2017 Madrid, Spain; 27th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany; Global Meeting on Oncology and Radiology April 16-17, 2018 Dubai, UAE; 4th Annual Conference on Gynecologic Oncology July 18-19, 2018 Atlanta, USA; World Haematology and Medical Oncology Conference May 28-30, 2018 Osaka, Japan; International Conference on Robotic Oncology October 26-27, 2018 Osaka, Japan; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2018 Rome, Italy; 

Track: Cancer Cell metabolism

Cancer metabolism is based on the principle that cancer cells, as related to normal cells, have different metabolic activities in order to support their enhanced energy and anabolic requirements. The pioneering discovery by Otto Warburg in the middle of the 20th century led to the observation that metabolic activity in tumor tissues leads to a ten-fold increase in production of lactate (from glucose) under aerobic conditions. This revelation developed a significant interest and led industry stakeholders to target metabolic pathways in an effort to find the treatment of cancer. In addition, several academic players have also initiated studies to explore the functional consequences of alterations in various metabolic pathways.

Related conferences

World Haematology and Medical Oncology Conference May 28-30, 2018 Osaka, Japan; International Conference on Robotic Oncology October 26-27, 2018 Osaka, Japan; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2018 Rome, Italy; 3rd Oncologist & Diagnostics Conference 2018 September 20-21, 2018 Germany, Berlin; 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA; 4th Annual Conference on Preventive oncology July 18-19, 2018 Atlanta, USA; 28th Euro Congress on Cancer Science & Therapy August 09-10, 2018 Madrid, Spain;

Track: Tumor Cell Metabolism Imaging

Molecular imaging of tumor metabolism has obtained considerable interest, since preclinical studies have indicated a close relationship between the activation of various oncogenes and alterations of cellular metabolism. Furthermore, several clinical trials have shown that metabolic imaging can significantly impact patient management by improving tumor staging, restaging, radiation treatment planning, and monitoring of tumor response to therapy. In this topic includes recent data on the molecular mechanisms underlying the increased metabolic activity of cancer cells and discuss imaging techniques for studies of tumor glucose, lipid, and amino acid metabolism.

Related conferences

World Haematology and Medical Oncology Conference May 28-30, 2018 Osaka, Japan; International Conference on Robotic Oncology October 26-27, 2018 Osaka, Japan; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2018 Rome, Italy; 3rd Oncologist & Diagnostics Conference 2018 September 20-21, 2018 Germany, Berlin; 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA; 4th Annual Conference on Preventive oncology July 18-19, 2018 Atlanta, USA; 28th Euro Congress on Cancer Science & Therapy August 09-10, 2018 Madrid, Spain;

Track: Cancer biology and therapeutics

Cancer cells display critical metabolic transformations induced by mutations that result in cell cycle deregulation associated with enhanced cellular stress. Adaptation to this stress phenotype is required for cancer cells to survive and involves the participation of genes that regulate metabolism, bioenergetics, cell death and ROS detoxification. In this text, small molecules that selectively kill cancer cells while sparing normal surrounding cells, are the desired approach for the treatment of cancer. To this aim, cancer therapeutics should target the differential features of cancer cells. Here, we briefly summarize the therapeutic strategies that involve mitochondria and their proposed mechanism of action to selectively target transformed cells.\

Related conferences

Experts Meet On Cancer Therapy 2018 July 11-12, 2018 Sydney, Australia; Global Summit on Oncology & Cancer March 12-14, 2018 Singapore; 3rd International Conference on Nuclear Medicine & Radiation Therapy March 26-27, 2018 Edinburgh, Scotland; 22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan; 9th World Biomarkers Congress December 07-08, 2017 Madrid, Spain; 27th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany; Global Meeting on Oncology and Radiology April 16-17, 2018 Dubai, UAE; 4th Annual Conference on Gynecologic Oncology July 18-19, 2018 Atlanta, USA; 

Track: Cytopathology

Cytopathology is a branch of pathology that studies and diagnoses diseases on the cellular level. The discipline was founded by George Nicolas Papanicolaou in 1928. Cytopathology is generally used on samples of free cells or tissue fragments, in contrast to histopathology, which studies whole tissues. A cytopathologist is an anatomic pathologist trained in the diagnosis of human disease by means of the study of cells obtained from body secretions and fluids by scraping, washing, or sponging the surface of a lesion, or by the aspiration of a tumor mass or body organ with a fine needle. A major aspect of a cytopathologist’s practice is the interpretation of Papanicolaou-stained smears of cells from the female reproductive systems. However, the cytopathologist’s expertise is applied to the diagnosis of cells from all systems and areas of the body. The cytopathologist is a consultant to all medical specialists.

Related conferences

4th Annual Conference on Gynecologic Oncology July 18-19, 2018 Atlanta, USA; World Haematology and Medical Oncology Conference May 28-30, 2018 Osaka, Japan; International Conference on Robotic Oncology October 26-27, 2018 Osaka, Japan; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2018 Rome, Italy; 3rd Oncologist & Diagnostics Conference 2018 September 20-21, 2018 Germany, Berlin; 2nd International Conference on Cancer Biology and Drug Delivery October 03-04, 2018 Los Angeles, California, USA; 4th Annual Conference on Preventive oncology July 18-19, 2018 Atlanta, USA; 28th Euro Congress on Cancer Science & Therapy August 09-10, 2018 Madrid, Spain;

Market Analysis

The cell-based assays market is expected to reach USD 19.92 Billion by 2022 from USD 13.34 Billion in 2017, at a CAGR of 8.4% during the forecast period from 2017 to 2022.

Two major factors are driving growth in cellular biology: a recent surge in NIH/NSF funding and the ongoing need for biological relevance in drug discovery. The anticipated infusion of nearly $38 billion in funding for the NIH/NSF by the Obama administration this year is certain to keep academia busy and shareholders interested.In addition, the rapid discovery of cellular pathways and molecules is providing pharmaceutical and biotech firms with a large number of potential drug targets. Despite improvements in analysis technologies, however, the ability to thoroughly understand a potential drug’s biological profile remains difficult.

The key players in the cell-based assays market include Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), PerkinElmer Inc. (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.K), Thermo Fisher Scientific Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), BioTek Instruments, Inc. (U.S.), Lonza Group (U.S.), ProQinase GmbH (Germany), Charles River Laboratories, Inc (U.S.), Cisbio Bioassays (France), Miltenyi Biotec (Germany), Cell Biolabs, Inc. (U.S.), DiscoverX Corporation (U.S.), Marin Biologic Laboratories (U.S.), Biospherix, Ltd (U.S.), Essen BioScience Inc. (U.S.), Cell Biologics Inc. (U.S.), BioAgilytix Labs. (U.S.), Enzo Life Sciences, Inc. (Switzerland), Aurelia Bioscience Ltd. (U.K. ), Selexis SA (U.S.), and QGel SA (Switzerland).

Target Audience for this Report:

  • Cell-based assays manufacturers and vendors
  • Research associations related to drug discovery
  • Healthcare providers (hospitals, laboratories, medical schools, and outpatient clinics)
  • Various research and consulting firms
  • Distributors of cell-based assays
  • Academic and Research Institutes

Scope of the Report:

This report categorizes the market into the following segments:

Cell-based Assays Market, by Product

  • Consumables
    • Reagents
    • Assay Kits
      • Reporter Gene Assays
      • Cell Growth Assays
      • Second Messenger Assays
      • Cell Death Assays
      • Other Assays
    • Microplates
    • Cell Lines
    • Immortalized Cell Lines
    • Primary Cell Lines
    • Stem Cell Lines
    • Probes and Labels
    • Other Consumables
  • Instruments
  • Services
  • Software

Cell-based Assays Market, by Application

  • Drug discovery
  • Basic Research
  • ADME Studies
  • Predictive Toxicology
  • Other Applications

Cell-Based Assays Market, by End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Government Institutions
  • Contract Research Organizations
  • Other End Users

Cell-Based Assays Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
  • France
  • U.K.
  • Germany
  • Spain
  • Italy
  • Rest of Europe (RoE)
  • China
  • Japan
  • India
  • Rest of Asia-Pacific (RoAPAC)
  • Asia-Pacific
  • Rest of the World (RoW)

DETAILED REVIEW OF THE CURRENT CELL CULTURE MARKET

Analysis of:

·      3D Cell Culture

·      Cell based assays

·      Assessment of current forms of matrix technology

·      Drivers and Barriers

·      Competitive Landscape

Conference Highlights

·         Cell Metabolism

·         Metabolic pathways

·         Metabolic disease Therapies

·         Neuro Immune Axis

·         Emerging re-emerging viruses

·         Human Immunity

·         Next gen Immunology

·         Translational immunometabolism

·         Translational Regulation in Development and Disease

·         Aging and Metabolism

·         Cancer Cell metabolism

·         Tumor Cell Metabolism Imaging

·         Cancer biology and therapeutics

To Collaborate Scientific Professionals around the World

Conference Date September 19 - 20, 2018

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Day 1 Day 2

Past Conference Report

Supported By

Journal of Cell Science & Therapy Journal of Cell Signaling Journal of Cancer Science & Therapy

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Keytopics

  • Cell Death
  • Adaptive Immune Ssytem
  • AllergyAutoimmune
  • Anabolic Pathways
  • Angiogenesis
  • Cancer Immunology
  • Catabolic Pathways
  • Cell & Tissue Architecture
  • Cell Biology
  • Cell Cycle More
  • Cell Proliferation
  • Cellular Immunology
  • Cellular Metabolism
  • Chromatin & Transcription
  • Clinical Immunology
  • Development
  • Differentiation & Death
  • Evolution & Ecology
  • Genome Stability & Dynamics
  • Genomic & Computational Biology
  • Glycolytic Metabolism
  • Immunology
  • Innate Adaptive Immunity
  • Membranes & Transport
  • Metabolite Profiling
  • Microbiology, Virology & Pathogens
  • Molecular Medicine
  • Molecular Microbiology
  • Neuroscience
  • Plant Biology
  • Plant Cell Biology
  • Proteins & Biochemistry
  • RNA
  • Signal Transduction
  • Stem Cell Renewal
  • Structural Biology & Biophysics
  • Systems Biology
  • Tumor Cell Metabolism